KELSEY ROTHENBERG: Open Payments
NPI 1083252357 · CONCORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,107 in 129 payments from 11 companies in 2025. Trend: 2023 $2,158 · 2024 $2,951 · 2025 $2,107
Food & beverage: $1,918Education: $189
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 54 | $806 |
| Neurocrine BioSciences, Inc. | 22 | $330 |
| Vanda Pharmaceuticals Inc. | 15 | $286 |
| Alkermes, Inc. | 11 | $237 |
| ABBVIE INC. | 13 | $183 |
| E.R. Squibb & Sons, L.L.C. | 5 | $90 |
| Indivior Inc. | 3 | $66 |
| Lundbeck LLC | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
Products named: AUSTEDO XR, INGREZZA, HETLIOZ, ARISTADA, VRAYLAR, UZEDY, COBENFY, SUBLOCADE.
Industry payments across NC — which companies pay providers there.
